why choose us

First received: June 09, 2023

Clinical Trial: Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Melanoma

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of INCB099280 in Combination With Ipilimumab in Participants With Select Solid Tumors

Brief Summary: The purpose of this study is to characterize the safety, tolerability, PK, and efficacy of INCB 99280 in combination with ipilimumab in participants with select solid tumors.

Read more